Meeting of the Advisory Commission on Childhood Vaccines, 2010 [2025-00389]
Download as PDF
<![CDATA[
2010
Federal Register / Vol. 90, No. 6 / Friday, January 10, 2025 / Notices
the Commissioner or designee from
among authorities knowledgeable in the
fields of science or engineering,
applicable to electronic product
radiation safety. Members will be
invited to serve for overlapping terms of
up to 4 years. Terms of more than 2
years are contingent upon the renewal
of the committee by appropriate action
prior to its expiration.
III. Nomination Procedures
Any interested person may nominate
one or more qualified individuals for
membership on the committee. Selfnominations are also accepted.
Nominations must include a current,
complete résumé or curriculum vitae for
each nominee, including current
business address and/or home address,
telephone number, and email address if
available and a signed copy of the
Acknowledgement and Consent form
available at the FDA Advisory
Nomination Portal (see ADDRESSES).
Nominations must also specify the
advisory committee for which the
nominee is recommended. Nominations
must also acknowledge that the
nominee is aware of the nomination
unless self-nominated. FDA will ask
potential candidates to provide detailed
information concerning such matters
related to financial holdings,
employment, and research grants and/or
contracts to permit evaluation of
possible sources of conflicts of interest.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. 1001 et seq.), and 21 CFR part 14,
relating to advisory committees.
Dated: December 27, 2024.
P. Ritu Nalubola,
Associate Commissioner for Policy.
[FR Doc. 2025–00310 Filed 1–8–25; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Meeting of the Advisory Commission
on Childhood Vaccines
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice.
khammond on DSK9W7S144PROD with NOTICES
AGENCY:
In accordance with the
Federal Advisory Committee Act, this
notice announces that the Advisory
Commission on Childhood Vaccines
(ACCV) has scheduled a public meeting.
Information about ACCV and the agenda
for this meeting can be found on the
SUMMARY:
VerDate Sep<11>2014
17:28 Jan 08, 2025
Jkt 265001
ACCV website at https://www.hrsa.gov/
advisory-committees/vaccines/
index.html.
DATES: The ACCV meeting will be held
on January 29, 2025, 12 p.m. eastern
time (ET)–4 p.m. ET and January 30,
2025, 12 p.m. ET–4 p.m. ET.
ADDRESSES: The meeting will be held by
Zoom webinar. For meeting information
updates and instructions for joining
remote meetings, go to the ACCV
website meeting page at https://
www.hrsa.gov/advisory-committees/
vaccines/meetings.html.
FOR FURTHER INFORMATION CONTACT: Pita
Gomez, Principal Staff Liaison, Division
of Injury Compensation Programs,
HRSA, 5600 Fishers Lane, 8W–25A,
Rockville, Maryland 20857; 800–338–
2382; or ACCV@hrsa.gov.
SUPPLEMENTARY INFORMATION: ACCV
provides advice and recommendations
to the Secretary of Health and Human
Services on policy, program
development, and other matters of
significance related to implementation
of the National Vaccine Injury
Compensation Program and concerning
other matters as described under section
2119 of the Public Health Service Act
(42 U.S.C. 300aa–19).
Since priorities dictate meeting times,
be advised that start times, end times,
and agenda items are subject to change.
Refer to the ACCV website listed above
for any meeting updates that may occur.
For the January 2025 meeting, agenda
items may include, but are not limited
to: updates from the Division of Injury
Compensation Programs, Department of
Justice, Office of Infectious Disease and
HIV/AIDS Policy (Department of Health
and Human Services), Immunization
Safety Office (Centers for Disease
Control and Prevention), National
Institute of Allergy and Infectious
Diseases (National Institutes of Health),
and Center for Biologics Evaluation and
Research (Food and Drug
Administration). Refer to the ACCV
website listed above for all current and
updated information concerning the
January 2025 ACCV meeting, including
the draft agenda that will be posted 15
calendar days before the meeting.
This meeting is open to the public
and requires registration. Registration
details will be provided on our ACCV
website at https://www.hrsa.gov/
advisory-committees/vaccines/
meetings.html. All registrants will be
asked to provide their name, affiliation,
and email address. After registration,
individuals will receive personalized
Zoom information via email.
Members of the public will have the
opportunity to provide comments.
Public participants may submit written
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
statements in advance of the meeting.
Oral comments will be honored in the
order they are requested and may be
limited as time allows. Requests to
submit a written statement or make oral
comments to ACCV should be sent to
Pita Gomez using the contact
information above at least 5 business
days before the meeting date.
Individuals who need special
assistance or another reasonable
accommodation should notify Pita
Gomez using the contact information
listed above at least 10 business days
before the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2025–00389 Filed 1–8–25; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of Minority Health,
Organizational Structure
Office of Minority Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
AGENCY:
This notice provides an
update to the organizational structure
for the Department of Health and
Human Services (HHS), Office of the
Secretary (OS), Office of Minority
Health (OMH). OMH has changed the
name of the Division of Information and
Education (DIE acronym), as noted in an
April 11, 1995 Federal Register Notice,
to the Division of Strategic
Communication and Community
Engagement (DCE acronym). This name
change better aligns with the functions
of the division and provides for a more
socially acceptable acronym. The
functions of the division are unchanged
from the April 11, 1995 Federal Register
Notice.
SUPPLEMENTARY INFORMATION: OMH
develops policies and programs for the
improvement of the health status of
racial and ethnic minority populations
and coordinates minority health
activities across HHS. The
establishment of OMH is noted in 50 FR
50847–48 (December 12, 1985). OMH’s
organization, functions, and delegations
of authority are noted in 60 FR 18418–
19 (April 11, 1995), as amended in 78
FR 59699–700 (September 27, 2013).
This notice provides an update to Part
A, Office of the Secretary, Statement of
Organization, Functions, and
Delegations of Authority for the U.S.
Department of Health and Human
Services at Chapter AC, to change the
name of the OMH Division of
SUMMARY:
E:\FR\FM\10JAN1.SGM
10JAN1
]]>Agencies
[Federal Register Volume 90, Number 6 (Friday, January 10, 2025)]
[Notices]
[Page 2010]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-00389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) has scheduled a public meeting. Information about ACCV and the
agenda for this meeting can be found on the ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/.
DATES: The ACCV meeting will be held on January 29, 2025, 12 p.m.
eastern time (ET)-4 p.m. ET and January 30, 2025, 12 p.m. ET-4 p.m. ET.
ADDRESSES: The meeting will be held by Zoom webinar. For meeting
information updates and instructions for joining remote meetings, go to
the ACCV website meeting page at https://www.hrsa.gov/advisory-committees/vaccines/meetings.html.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 8W-
25A, Rockville, Maryland 20857; 800-338-2382; or [email protected].
SUPPLEMENTARY INFORMATION: ACCV provides advice and recommendations to
the Secretary of Health and Human Services on policy, program
development, and other matters of significance related to
implementation of the National Vaccine Injury Compensation Program and
concerning other matters as described under section 2119 of the Public
Health Service Act (42 U.S.C. 300aa-19).
Since priorities dictate meeting times, be advised that start
times, end times, and agenda items are subject to change. Refer to the
ACCV website listed above for any meeting updates that may occur. For
the January 2025 meeting, agenda items may include, but are not limited
to: updates from the Division of Injury Compensation Programs,
Department of Justice, Office of Infectious Disease and HIV/AIDS Policy
(Department of Health and Human Services), Immunization Safety Office
(Centers for Disease Control and Prevention), National Institute of
Allergy and Infectious Diseases (National Institutes of Health), and
Center for Biologics Evaluation and Research (Food and Drug
Administration). Refer to the ACCV website listed above for all current
and updated information concerning the January 2025 ACCV meeting,
including the draft agenda that will be posted 15 calendar days before
the meeting.
This meeting is open to the public and requires registration.
Registration details will be provided on our ACCV website at https://www.hrsa.gov/advisory-committees/vaccines/meetings.html. All
registrants will be asked to provide their name, affiliation, and email
address. After registration, individuals will receive personalized Zoom
information via email.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the meeting. Oral comments will be honored in the order they are
requested and may be limited as time allows. Requests to submit a
written statement or make oral comments to ACCV should be sent to Pita
Gomez using the contact information above at least 5 business days
before the meeting date.
Individuals who need special assistance or another reasonable
accommodation should notify Pita Gomez using the contact information
listed above at least 10 business days before the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2025-00389 Filed 1-8-25; 8:45 am]
BILLING CODE 4165-15-P
